Approaches to antifungal therapy in the intensive care unit.

摘要: The risk of fungal infection is increasing in intensive care unit patients and the spectrum pathogens changing. A number new antifungal agents are becoming available, but their use critically ill has not been assessed randomized controlled trials. Furthermore, distinguishing colonization from problematic patients. Clinicians who involved management must remain vigilant devise a risk-based strategy that based on local experience susceptibility patterns.